Liz Johnson
wired4story
The past 8 years has seen a lot of targeted therapies for ER+ breast cancer.#MBCImpactNJ @komennewjersey Immunotherapy is being combined with CDK4/6 with some success in the lab. Not yet
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.